Two-layered dissolving microneedles for percutaneous delivery of sumatriptan in rats
暂无分享,去创建一个
[1] J. Rothrock. Injectable Sumatriptan: Now Needle‐Based or Needle‐Free , 2010, Headache.
[2] A. Fox,et al. Rapid Oral Transmucosal Absorption of Sumatriptan, and Pharmacodynamics in Acute Migraine , 2009, Headache.
[3] R. Cady,et al. Needle‐Free Subcutaneous Sumatriptan (Sumavel™ DosePro™): Bioequivalence and Ease of Use , 2009, Headache.
[4] S. Siegel,et al. Zelrix™: A Novel Transdermal Formulation of Sumatriptan , 2009, Headache.
[5] Yukako Ito,et al. Self-dissolving micropiles for the percutaneous absorption of recombinant human growth hormone in rats. , 2008, Biological & pharmaceutical bulletin.
[6] K. Takada. Microfabrication-derived DDS: From batch to individual production. , 2008, Drug discoveries & therapeutics.
[7] N. Hibino,et al. A novel method to reduce pericardial adhesion: a combination technique with hyaluronic acid biocompatible membrane. , 2008, The Journal of thoracic and cardiovascular surgery.
[8] Yukako Ito,et al. Antihyperglycemic effect of insulin from self-dissolving micropiles in dogs. , 2008, Chemical & pharmaceutical bulletin.
[9] A. Bertolini,et al. Interindividual variability of oral sumatriptan pharmacokinetics and of clinical response in migraine patients , 2008, European Journal of Clinical Pharmacology.
[10] Yukako Ito,et al. Percutaneous absorption of interferon-α by self-dissolving micropiles , 2008 .
[11] Saleh Hussain,et al. An evaporation-free solid-phase extraction method for rapid and accurate analysis of sumatriptan in human plasma by LC-MS/MS. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[12] J. Yoshimitsu,et al. Pharmacokinetic and pharmacodynamic studies following percutaneous absorption of erythropoietin micropiles to rats. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[13] L. Dubé,et al. A Unique Iontophoretic Patch for Optimal Transdermal Delivery of Sumatriptan , 2007, Pharmaceutical Research.
[14] Y. Kalia,et al. In vitro and in vivo evaluation of the transdermal iontophoretic delivery of sumatriptan succinate. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[15] P. Winner,et al. Nasal Delivery of Antimigraine Drugs: Clinical Rationale and Evidence Base , 2006, Headache.
[16] Kanji Takada,et al. Feasibility of microneedles for percutaneous absorption of insulin. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[17] Mark G. Allen,et al. Polymer Microneedles for Controlled-Release Drug Delivery , 2006, Pharmaceutical Research.
[18] Sha Huang,et al. Release of bioactive BMP from dextran-derived microspheres: a novel delivery concept. , 2006, International journal of pharmaceutics.
[19] J. Yoshimitsu,et al. Self-dissolving microneedles for the percutaneous absorption of EPO in mice , 2006, Journal of drug targeting.
[20] R. Lipton,et al. The global burden of migraine: measuring disability in headache disorders with WHO's Classification of Functioning, Disability and Health (ICF) , 2005, The Journal of Headache and Pain.
[21] N. Marcon,et al. Biodegradable dextran-based microspheres for delivery of anticancer drug mitomycin C. , 2005, Biomaterials.
[22] Mark G. Allen,et al. Hollow metal microneedles for insulin delivery to diabetic rats , 2005, IEEE Transactions on Biomedical Engineering.
[23] Melissa Ai Ling Teo,et al. In Vitro and In Vivo Characterization of MEMS Microneedles , 2005, Biomedical microdevices.
[24] Mark G. Allen,et al. Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: Fabrication methods and transport studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[25] R. Ryan. Patient treatment preferences and the 5-HT1B/1D agonists. , 2001, Archives of internal medicine.
[26] M. Allen,et al. Microfabricated microneedles: a novel approach to transdermal drug delivery. , 1998, Journal of pharmaceutical sciences.
[27] E. Fuseau,et al. Comparative clinical pharmacokinetics of single doses of sumatriptan following subcutaneous, oral, rectal and intranasal administration. , 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[28] G. Volans. Migraine and Drug Absorption , 1978, Clinical pharmacokinetics.
[29] R. Luthringer,et al. Rapid absorption of sumatriptan powder and effects on glyceryl trinitrate model of headache following intranasal delivery using a novel bi-directional device. , 2009, The Journal of pharmacy and pharmacology.
[30] M. Danhof,et al. Relevance of Absorption Rate and Lag Time to the Onset of Action in Migraine , 2008, Clinical pharmacokinetics.
[31] Yukako Ito,et al. Percutaneous absorption of interferon-alpha by self-dissolving micropiles. , 2008, Journal of drug targeting.